Medical - Devices
Compare Stocks
3 / 10Stock Comparison
IRTC vs ITGR vs INVA
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Devices
Biotechnology
IRTC vs ITGR vs INVA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Medical - Devices | Medical - Devices | Biotechnology |
| Market Cap | $4.10B | $3.03B | $1.93B |
| Revenue (TTM) | $788M | $1.85B | $424M |
| Net Income (TTM) | $-28M | $142M | $504M |
| Gross Margin | 71.0% | 23.3% | 76.2% |
| Operating Margin | -3.3% | 10.4% | 14.8% |
| Forward P/E | — | 13.5x | 11.9x |
| Total Debt | $731M | $1.40B | $269M |
| Cash & Equiv. | $236M | $17M | $551M |
IRTC vs ITGR vs INVA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| iRhythm Technologie… (IRTC) | 100 | 100.5 | +0.5% |
| Integer Holdings Co… (ITGR) | 100 | 111.0 | +11.0% |
| Innoviva, Inc. (INVA) | 100 | 163.2 | +63.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IRTC vs ITGR vs INVA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IRTC is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 26.2%, EPS growth 61.7%, 3Y rev CAGR 22.1%
- 379.3% 10Y total return vs INVA's 94.9%
- 26.2% revenue growth vs ITGR's 7.6%
ITGR plays a supporting role in this comparison — it may shine differently against other peers.
INVA carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 0 yrs, beta 0.13
- Lower volatility, beta 0.13, Low D/E 22.9%, current ratio 14.64x
- PEG 1.15 vs ITGR's 3.08
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 26.2% revenue growth vs ITGR's 7.6% | |
| Value | Lower P/E (11.9x vs 13.5x), PEG 1.15 vs 3.08 | |
| Quality / Margins | 118.9% margin vs IRTC's -3.5% | |
| Stability / Safety | Beta 0.13 vs IRTC's 0.93, lower leverage | |
| Dividends | Tie | None of these 3 stocks pay a meaningful dividend |
| Momentum (1Y) | +21.7% vs ITGR's -26.1% | |
| Efficiency (ROA) | 32.4% ROA vs IRTC's -2.8%, ROIC 14.2% vs -5.2% |
IRTC vs ITGR vs INVA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
IRTC vs ITGR vs INVA — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
INVA leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ITGR is the larger business by revenue, generating $1.8B annually — 4.4x INVA's $424M. INVA is the more profitable business, keeping 118.9% of every revenue dollar as net income compared to IRTC's -3.5%. On growth, IRTC holds the edge at +25.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $788M | $1.8B | $424M |
| EBITDAEarnings before interest/tax | -$6M | $328M | $86M |
| Net IncomeAfter-tax profit | -$28M | $142M | $504M |
| Free Cash FlowCash after capex | $19M | $168M | $181M |
| Gross MarginGross profit ÷ Revenue | +71.0% | +23.3% | +76.2% |
| Operating MarginEBIT ÷ Revenue | -3.3% | +10.4% | +14.8% |
| Net MarginNet income ÷ Revenue | -3.5% | +7.7% | +118.9% |
| FCF MarginFCF ÷ Revenue | +2.4% | +9.1% | +42.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +25.7% | +0.8% | +10.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +55.7% | +172.7% | +4.0% |
Valuation Metrics
INVA leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 6.9x trailing earnings, INVA trades at a 77% valuation discount to ITGR's 30.4x P/E. Adjusting for growth (PEG ratio), INVA offers better value at 0.67x vs ITGR's 6.91x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $4.1B | $3.0B | $1.9B |
| Enterprise ValueMkt cap + debt − cash | $4.6B | $4.4B | $1.7B |
| Trailing P/EPrice ÷ TTM EPS | -89.83x | 30.42x | 6.91x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 13.55x | 11.91x |
| PEG RatioP/E ÷ EPS growth rate | — | 6.91x | 0.67x |
| EV / EBITDAEnterprise value multiple | — | 13.15x | 8.10x |
| Price / SalesMarket cap ÷ Revenue | 5.49x | 1.64x | 4.55x |
| Price / BookPrice ÷ Book value/share | 26.16x | 1.79x | 1.65x |
| Price / FCFMarket cap ÷ FCF | 118.84x | 28.78x | 9.88x |
Profitability & Efficiency
INVA leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
INVA delivers a 46.5% return on equity — every $100 of shareholder capital generates $46 in annual profit, vs $-21 for IRTC. INVA carries lower financial leverage with a 0.23x debt-to-equity ratio, signaling a more conservative balance sheet compared to IRTC's 4.79x. On the Piotroski fundamental quality scale (0–9), IRTC scores 6/9 vs INVA's 5/9, reflecting solid financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | -20.6% | +8.2% | +46.5% |
| ROA (TTM)Return on assets | -2.8% | +4.2% | +32.4% |
| ROICReturn on invested capital | -5.2% | +5.4% | +14.2% |
| ROCEReturn on capital employed | -4.4% | +6.9% | +12.4% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 5 |
| Debt / EquityFinancial leverage | 4.79x | 0.80x | 0.23x |
| Net DebtTotal debt minus cash | $495M | $1.4B | -$282M |
| Cash & Equiv.Liquid assets | $236M | $17M | $551M |
| Total DebtShort + long-term debt | $731M | $1.4B | $269M |
| Interest CoverageEBIT ÷ Interest expense | -1.48x | 5.07x | 63.45x |
Total Returns (Dividends Reinvested)
INVA leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in INVA five years ago would be worth $19,437 today (with dividends reinvested), compared to $9,252 for ITGR. Over the past 12 months, INVA leads with a +21.7% total return vs ITGR's -26.1%. The 3-year compound annual growth rate (CAGR) favors INVA at 25.0% vs IRTC's -0.7% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | -28.7% | +14.5% | +14.7% |
| 1-Year ReturnPast 12 months | -8.3% | -26.1% | +21.7% |
| 3-Year ReturnCumulative with dividends | -2.1% | +8.8% | +95.2% |
| 5-Year ReturnCumulative with dividends | +56.1% | -7.5% | +94.4% |
| 10-Year ReturnCumulative with dividends | +379.3% | +165.1% | +94.9% |
| CAGR (3Y)Annualised 3-year return | -0.7% | +2.9% | +25.0% |
Risk & Volatility
INVA leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
INVA is the less volatile stock with a 0.13 beta — it tends to amplify market swings less than IRTC's 0.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. INVA currently trades 90.7% from its 52-week high vs IRTC's 58.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.93x | 0.72x | 0.13x |
| 52-Week HighHighest price in past year | $212.00 | $123.78 | $25.15 |
| 52-Week LowLowest price in past year | $112.31 | $62.00 | $16.52 |
| % of 52W HighCurrent price vs 52-week peak | +58.9% | +71.0% | +90.7% |
| RSI (14)Momentum oscillator 0–100 | 44.1 | 50.9 | 39.9 |
| Avg Volume (50D)Average daily shares traded | 524K | 628K | 621K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: IRTC as "Buy", ITGR as "Buy", INVA as "Buy". Consensus price targets imply 65.2% upside for INVA (target: $38) vs 11.5% for ITGR (target: $98).
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $193.67 | $98.00 | $37.67 |
| # AnalystsCovering analysts | 19 | 14 | 10 |
| Dividend YieldAnnual dividend ÷ price | — | — | — |
| Dividend StreakConsecutive years of raises | — | — | 0 |
| Dividend / ShareAnnual DPS | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.7% | +0.2% |
INVA leads in 5 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics.
IRTC vs ITGR vs INVA: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IRTC or ITGR or INVA a better buy right now?
For growth investors, iRhythm Technologies, Inc.
(IRTC) is the stronger pick with 26. 2% revenue growth year-over-year, versus 7. 6% for Integer Holdings Corporation (ITGR). Innoviva, Inc. (INVA) offers the better valuation at 6. 9x trailing P/E (11. 9x forward), making it the more compelling value choice. Analysts rate iRhythm Technologies, Inc. (IRTC) a "Buy" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IRTC or ITGR or INVA?
On trailing P/E, Innoviva, Inc.
(INVA) is the cheapest at 6. 9x versus Integer Holdings Corporation at 30. 4x. On forward P/E, Innoviva, Inc. is actually cheaper at 11. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Innoviva, Inc. wins at 1. 15x versus Integer Holdings Corporation's 3. 08x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — IRTC or ITGR or INVA?
Over the past 5 years, Innoviva, Inc.
(INVA) delivered a total return of +94. 4%, compared to -7. 5% for Integer Holdings Corporation (ITGR). Over 10 years, the gap is even starker: IRTC returned +379. 3% versus INVA's +94. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IRTC or ITGR or INVA?
By beta (market sensitivity over 5 years), Innoviva, Inc.
(INVA) is the lower-risk stock at 0. 13β versus iRhythm Technologies, Inc. 's 0. 93β — meaning IRTC is approximately 639% more volatile than INVA relative to the S&P 500. On balance sheet safety, Innoviva, Inc. (INVA) carries a lower debt/equity ratio of 23% versus 5% for iRhythm Technologies, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — IRTC or ITGR or INVA?
By revenue growth (latest reported year), iRhythm Technologies, Inc.
(IRTC) is pulling ahead at 26. 2% versus 7. 6% for Integer Holdings Corporation (ITGR). On earnings-per-share growth, the picture is similar: Innoviva, Inc. grew EPS 816. 7% year-over-year, compared to -15. 0% for Integer Holdings Corporation. Over a 3-year CAGR, IRTC leads at 22. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IRTC or ITGR or INVA?
Innoviva, Inc.
(INVA) is the more profitable company, earning 63. 8% net margin versus -6. 0% for iRhythm Technologies, Inc. — meaning it keeps 63. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: INVA leads at 38. 5% versus -4. 9% for IRTC. At the gross margin level — before operating expenses — INVA leads at 72. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IRTC or ITGR or INVA more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Innoviva, Inc. (INVA) is the more undervalued stock at a PEG of 1. 15x versus Integer Holdings Corporation's 3. 08x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Innoviva, Inc. (INVA) trades at 11. 9x forward P/E versus 13. 5x for Integer Holdings Corporation — 1. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for INVA: 65. 2% to $37. 67.
08Which pays a better dividend — IRTC or ITGR or INVA?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is IRTC or ITGR or INVA better for a retirement portfolio?
For long-horizon retirement investors, Innoviva, Inc.
(INVA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13)). Both have compounded well over 10 years (INVA: +94. 9%, IRTC: +379. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IRTC and ITGR and INVA?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: IRTC is a small-cap high-growth stock; ITGR is a small-cap quality compounder stock; INVA is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.